tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Immutep announces completion of FDA Project Optimus requirements
The FlyImmutep announces completion of FDA Project Optimus requirements
6d ago
IMMP
Immutep Completes FDA Project Optimus, Advances Cancer Immunotherapy
PremiumCompany Announcements
Immutep Completes FDA Project Optimus, Advances Cancer Immunotherapy
7d ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
9d ago
TIL
CBIO
Promising Developments in Immutep’s Clinical Trials Drive Buy Rating
PremiumRatings
Promising Developments in Immutep’s Clinical Trials Drive Buy Rating
9d ago
IMMP
Immutep announces update for TACTI-004 Phase III trial
PremiumThe Fly
Immutep announces update for TACTI-004 Phase III trial
10d ago
MRK
IMMP
Immutep Achieves Key Milestone in Phase III Lung Cancer Trial
PremiumCompany AnnouncementsImmutep Achieves Key Milestone in Phase III Lung Cancer Trial
11d ago
Immutep Director Converts Performance Rights into Shares
Premium
Company Announcements
Immutep Director Converts Performance Rights into Shares
12d ago
Immutep Ltd Announces Director’s Interest Change
Premium
Company Announcements
Immutep Ltd Announces Director’s Interest Change
12d ago
Immutep Ltd Announces Director’s Acquisition of Shares
PremiumCompany Announcements
Immutep Ltd Announces Director’s Acquisition of Shares
12d ago
Immutep Ltd Issues New Shares on ASX
PremiumCompany Announcements
Immutep Ltd Issues New Shares on ASX
18d ago
Immutep enters reseach collaboration with GW University Cancer Center
PremiumThe Fly
Immutep enters reseach collaboration with GW University Cancer Center
27d ago
IMMP
Immutep Collaborates with GW Cancer Center on Efti Trial for Breast Cancer
PremiumCompany Announcements
Immutep Collaborates with GW Cancer Center on Efti Trial for Breast Cancer
28d ago
Immutep’s Phase II Trial Data on Soft Tissue Sarcoma to be Presented at CTOS 2025
PremiumCompany AnnouncementsImmutep’s Phase II Trial Data on Soft Tissue Sarcoma to be Presented at CTOS 2025
1M ago
Immutep Reports Increased Loss Amid Rising R&D Costs
Premium
Company Announcements
Immutep Reports Increased Loss Amid Rising R&D Costs
2M ago
Immutep’s Strategic Advances and Promising Clinical Data Drive Buy Rating
Premium
Ratings
Immutep’s Strategic Advances and Promising Clinical Data Drive Buy Rating
2M ago
IMMP
Immutep receives FDA feedback on clinical development of eftilagimod alfa
PremiumThe Fly
Immutep receives FDA feedback on clinical development of eftilagimod alfa
3M ago
IMMP
Immutep Gains FDA Support for Cancer Therapy Development
PremiumCompany Announcements
Immutep Gains FDA Support for Cancer Therapy Development
3M ago
Immutep reports Q4 cash receipts from customers A$6,000
PremiumThe Fly
Immutep reports Q4 cash receipts from customers A$6,000
3M ago
IMMP
Immutep Advances Oncology Trials with Promising Results
PremiumCompany Announcements
Immutep Advances Oncology Trials with Promising Results
3M ago
Immutep’s Eftilagimod Alfa Trials to be Showcased at ESMO 2025
PremiumCompany AnnouncementsImmutep’s Eftilagimod Alfa Trials to be Showcased at ESMO 2025
3M ago
JPMorgan Ceases Substantial Holding in Immutep Ltd
Premium
Company Announcements
JPMorgan Ceases Substantial Holding in Immutep Ltd
3M ago
Immutep Ltd Reports Changes in Substantial Holdings
Premium
Company Announcements
Immutep Ltd Reports Changes in Substantial Holdings
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >